Koki Mimura

Koki Mimura

Auto-generated profile, based on publicly available information

Koki Mimura

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
KOKei Oyama
Kei Oyama
YHYukiko Hori
Yukiko Hori
YNYuji Nagai
Yuji Nagai
NMNaohisa Miyakawa
Naohisa Miyakawa
KMKoki Mimura
Koki Mimura
TMTakafumi Minamimoto
Takafumi Minamimoto
Imaging-guided selective silencing of the prefronto-caudate/thalamus pathways reveals their distinct roles in cognitive functions.

28 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KOKei Oyama
Kei Oyama
KMKei Majima
Kei Majima
YNYuji Nagai
Yuji Nagai
YHYukiko Hori
Yukiko Hori
THToshiyuki Hirabayashi
Toshiyuki Hirabayashi
TMTakafumi Minamimoto
Takafumi Minamimoto
Primates must adapt to changing environments by optimizing their behavior to make beneficial choices. At the core of adaptive behavior is the orbitofrontal cortex (OFC) of the brain, which updates choice value through direct experience or knowledge-based inference. Here, we identify distinct neural circuitry underlying these two separate abilities. We designed two behavioral tasks in which two male macaque monkeys updated the values of certain items, either by directly experiencing changes in stimulus-reward associations, or by inferring the value of unexperienced items based on the task’s rules. Chemogenetic silencing of bilateral OFC combined with mathematical model-fitting analysis revealed that monkey OFC is involved in updating item value based on both experience and inference. In vivo imaging of chemogenetic receptors by positron emission tomography allowed us to map projections from the OFC to the rostromedial caudate nucleus (rmCD) and the medial part of the mediodorsal thalamus (MDm). Chemogenetic silencing of the OFC-rmCD pathway impaired experience-based value updating, while silencing the OFC-MDm pathway impaired inference-based value updating. Our results thus demonstrate dissociable contributions of distinct OFC projections to different behavioral strategies, and provide new insights into the neural basis of value-based adaptive decision-making in primates.

1 July 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
YHYukiko Hori
Yukiko Hori
YNYuji Nagai
Yuji Nagai
KMKoki Mimura
Koki Mimura
TSTetsuya Suhara
Tetsuya Suhara
MHMakoto Higuchi
Makoto Higuchi
TMTakafumi Minamimoto
Takafumi Minamimoto
It has been widely accepted that dopamine (DA) plays a major role in motivation, yet the specific contribution of DA signaling at D1-like receptor (D1R) and D2-like receptor (D2R) to cost–benefit trade-off remains unclear. Here, by combining pharmacological manipulation of DA receptors (DARs) and positron emission tomography (PET) imaging, we assessed the relationship between the degree of D1R/D2R blockade and changes in benefit- and cost-based motivation for goal-directed behavior of macaque monkeys. We found that the degree of blockade of either D1R or D2R was associated with a reduction of the positive impact of reward amount and increasing delay discounting. Workload discounting was selectively increased by D2R antagonism. In addition, blocking both D1R and D2R had a synergistic effect on delay discounting but an antagonist effect on workload discounting. These results provide fundamental insight into the distinct mechanisms of DA action in the regulation of the benefit- and cost-based motivation, which have important implications for motivational alterations in both neurological and psychiatric disorders.

3 September 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
KMKoki Mimura
Koki Mimura
JMJumpei Matsumoto
Jumpei Matsumoto
DMDaichi Mochihashi
Daichi Mochihashi
TNTomoaki Nakamura
Tomoaki Nakamura
HNHisao Nishijo
Hisao Nishijo
TMTakafumi Minamimoto
Takafumi Minamimoto
Nonhuman primates (NHPs) exhibit complex and diverse behavior that typifies advanced cognitive function and social communication, but quantitative and systematical measure of this natural nonverbal processing has been a technical challenge. Specifically, a method is required to automatically segment time series of behavior into elemental motion motifs, much like finding meaningful words in character strings. Here, we propose a solution called SyntacticMotionParser (SMP), a general-purpose unsupervised behavior parsing algorithm using a nonparametric Bayesian model. Using three-dimensional posture-tracking data from NHPs, SMP automatically outputs an optimized sequence of latent motion motifs classified into the most likely number of states. When applied to behavioral datasets from common marmosets and rhesus monkeys, SMP outperformed conventional posture-clustering models and detected a set of behavioral ethograms from publicly available data. SMP also quantified and visualized the behavioral effects of chemogenetic neural manipulations. SMP thus has the potential to dramatically improve our understanding of natural NHP behavior in a variety of contexts.

9 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMasafumi Shimojo
Masafumi Shimojo
MOMaiko Ono
Maiko Ono
HTHiroyuki Takuwa
Hiroyuki Takuwa
KMKoki Mimura
Koki Mimura
YNYuji Nagai
Yuji Nagai
MHMakoto Higuchi
Makoto Higuchi
Positron Emission Tomography (PET) allows biomolecular tracking, while PET monitoring of brain networks has been hampered by the lack of a suitable reporter. Here, we describe in vivo brain imaging that takes advantage of bacterial dihydrofolate reductase, ecDHFR, and its unique antagonist, TMP. In mice, peripheral administration of radiofluorinated and fluorescent TMP analogs enabled PET and intravital microscopy, respectively, of neuronal ecDHFR expressions. This technique is applicable to the visualization of neuronal ensemble activities elicited by chemogenetic manipulation in the mouse hippocampus. Notably, ecDHFR-PET offers mapping of neuronal projections in non-human primate brains, indicating the availability of ecDHFR-based tracking technologies for network monitoring. Finally, we demonstrate the utility of TMP analogs for PET assays of turnover and self-assembly of proteins tagged with ecDHFR mutants. Our findings may facilitate a broad spectrum of PET analyses of a mammalian brain circuit at molecular levels that were not previously applicable for technical reasons.

26 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YNYuji Nagai
Yuji Nagai
YHYukiko Hori
Yukiko Hori
KIKen-ichi Inoue
Ken-ichi Inoue
THToshiyuki Hirabayashi
Toshiyuki Hirabayashi
KMKoki Mimura
Koki Mimura
TMTakafumi Minamimoto
Takafumi Minamimoto
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) offer a powerful means for reversible control of neuronal activity through systemic administration of inert actuators. Because chemogenetic control relies on DREADD expression levels, understanding and quantifying the temporal dynamics of their expression is crucial for planning long-term experiments in monkeys. In this study, we longitudinally quantified in vivo DREADD expression in macaque monkeys using positron emission tomography with the DREADD-selective tracer [ 11 C]deschloroclozapine (DCZ), complemented by functional studies. Twenty macaque monkeys were evaluated after being injected with adeno-associated virus vectors expressing the DREADDs hM4Di or hM3Dq, whose expression was quantified as changes in [ 11 C]DCZ binding potential from baseline levels. Expression levels of both hM4Di and hM3Dq peaked around 60 days post-injection, remained stable for about 1.5 years, and declined gradually after two years. Significant chemogenetic control of neural activity and behavior persisted for about two years. The presence of protein tags significantly influenced expression levels, with co-expressed protein tags reducing overall expression levels. These findings provide valuable insights and guidelines for optimizing the use of DREADDs in long-term primate studies and potential therapeutic applications.